Shingrix, a shingles vaccine in the U.S., provides seven to 10 years of protection following the initial two-dose ...

Jamie Mackelfresh, MD: Currently, the CDC recommends that adults over age 50, in particular, are the core people who should think about getting the shingles vaccine. There are two different ...

GPs and practice nurses are likely to offer the shingles vaccine during routine visits or check-ups. NHS England urged those eligible from September to take up the offer of the jab, saying it ...

Robert F. Kennedy Jr. may have a significant influence on public health matters following Donald Trump's presidential victory ...

If you take immunosuppressive drugs to treat rheumatoid ... If you’re about to start taking an immunosuppressant, it’s best ...

"It can take a long time to kind of get those nerves ... Cohen's research is waiting for peer review and publication. There is a vaccine for shingles that's more than 90% effective but only ...

Zero shingles cases after 18.8 months follow-up in 619 patients receiving any dose of amezosvatein, a development-stage adjuvanted subunit ...

“I’m optimistic and believe Shingrix will also be effective at reducing shingles and its sequelae, especially with how effective the vaccine has shown to be in other settings,” said Harris. Harris ...

There's a potential new treatment for people who develop shingles that spread to the eye. Doctors say about 8% of shingles ...

Nova Scotia's Progressive Conservatives promised on Tuesday to introduce a universal shingles vaccine program for people 65 and older if re-elected Nov. 26, the latest in a series of targeted ...

Based upon these results, Curevo will advance amezosvatein into global Phase 3 trials in 2025 to address a market for shingles vaccination currently ... have difficulty convincing our patients to take ...

“These data support our efforts to bring a new shingles vaccine to global markets,” stated George Simeon, Curevo’s Chief Executive Officer. “Though somewhat unsurprising, given ...